Search research articles
Contact Us
Filters
Showing results (201-210 of 229) with videos related to
Page
of 23
Sort By:
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
April 9, 2015
ELYPSE-7: a randomized placebo-controlled phase IIa trial with CYT107 exploring the restoration of CD4+ lymphocyte count in lymphopenic metastatic breast cancer patients
O Trédan, C Ménétrier-Caux, I Ray-Coquard, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
March 23, 2005
Consensus meeting for the management of gastrointestinal stromal tumors. Report of the GIST Consensus Conference of 20-21 March 2004, under the auspices of ESMO
J-Y Blay, S Bonvalot, P Casali, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
April 4, 2017
ELYPSE-7: a randomized placebo-controlled phase IIa trial with CYT107 exploring the restoration of CD4+ lymphocyte count in lymphopenic metastatic breast cancer patients
O Trédan, C Ménétrier-Caux, I Ray-Coquard, et al.
ESMO Open
|
May 20, 2025
HR-SC-an academic-developed machine learning framework to classify HRD-positive ovarian cancer patients and predict sensitivity to olaparib
L Beltrame, L Mannarino, A Sergi, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research
|
May 21, 2016
Economic Impact of Centralized Histological Reviews in Patients with Sarcoma, Gist, and Desmoid Tumors
L Perrier, Nzale S Kembou, P Rascle, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
September 6, 2024
A randomized study of 6 versus 3 years of adjuvant imatinib in patients with localized GIST at high risk of relapse
J-Y Blay, C Schiffler, O Bouché, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
November 9, 2017
Improved survival using specialized multidisciplinary board in sarcoma patients
J-Y Blay, P Soibinet, N Penel, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
November 8, 2012
Osteosarcomas of the mandible: multidisciplinary management of a rare tumor of the young adult a cooperative study of the GSF-GETO, Rare Cancer Network, GETTEC/REFCOR and SFCE
J Thariat, T Schouman, A Brouchet, et al.
Gynecologic Oncology
|
March 6, 2020
The French national network dedicated to rare gynecological cancers diagnosis and management could improve the quality of surgery in daily practice of granulosa cell tumors. A TMRG and GINECO group Study
C Lenck, N Chopin, S Gouy, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
May 21, 2023
Olaparib plus bevacizumab first-line maintenance in ovarian cancer: final overall survival results from the PAOLA-1/ENGOT-ov25 trial
I Ray-Coquard, A Leary, S Pignata, et al.
Page
of 23
Search research articles
Search
Showing results (201-210 of 229) with videos related to
Sort By:
Page
of 23
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
April 9, 2015
ELYPSE-7: a randomized placebo-controlled phase IIa trial with CYT107 exploring the restoration of CD4+ lymphocyte count in lymphopenic metastatic breast cancer patients
O Trédan, C Ménétrier-Caux, I Ray-Coquard, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
March 23, 2005
Consensus meeting for the management of gastrointestinal stromal tumors. Report of the GIST Consensus Conference of 20-21 March 2004, under the auspices of ESMO
J-Y Blay, S Bonvalot, P Casali, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
April 4, 2017
ELYPSE-7: a randomized placebo-controlled phase IIa trial with CYT107 exploring the restoration of CD4+ lymphocyte count in lymphopenic metastatic breast cancer patients
O Trédan, C Ménétrier-Caux, I Ray-Coquard, et al.
ESMO Open
|
May 20, 2025
HR-SC-an academic-developed machine learning framework to classify HRD-positive ovarian cancer patients and predict sensitivity to olaparib
L Beltrame, L Mannarino, A Sergi, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research
|
May 21, 2016
Economic Impact of Centralized Histological Reviews in Patients with Sarcoma, Gist, and Desmoid Tumors
L Perrier, Nzale S Kembou, P Rascle, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
September 6, 2024
A randomized study of 6 versus 3 years of adjuvant imatinib in patients with localized GIST at high risk of relapse
J-Y Blay, C Schiffler, O Bouché, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
November 9, 2017
Improved survival using specialized multidisciplinary board in sarcoma patients
J-Y Blay, P Soibinet, N Penel, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
November 8, 2012
Osteosarcomas of the mandible: multidisciplinary management of a rare tumor of the young adult a cooperative study of the GSF-GETO, Rare Cancer Network, GETTEC/REFCOR and SFCE
J Thariat, T Schouman, A Brouchet, et al.
Gynecologic Oncology
|
March 6, 2020
The French national network dedicated to rare gynecological cancers diagnosis and management could improve the quality of surgery in daily practice of granulosa cell tumors. A TMRG and GINECO group Study
C Lenck, N Chopin, S Gouy, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
May 21, 2023
Olaparib plus bevacizumab first-line maintenance in ovarian cancer: final overall survival results from the PAOLA-1/ENGOT-ov25 trial
I Ray-Coquard, A Leary, S Pignata, et al.
Page
of 23